GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 194 filers reported holding GW PHARMACEUTICALS PLC in Q1 2018. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $82,000 | +70.8% | 475 | +11.8% | 0.02% | +72.7% |
| Q1 2018 | $48,000 | -14.3% | 425 | 0.0% | 0.01% | -21.4% |
| Q4 2017 | $56,000 | -33.3% | 425 | -48.5% | 0.01% | -33.3% |
| Q3 2017 | $84,000 | -9.7% | 825 | -10.8% | 0.02% | -19.2% |
| Q2 2017 | $93,000 | +447.1% | 925 | +516.7% | 0.03% | +420.0% |
| Q1 2017 | $17,000 | 0.0% | 150 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $17,000 | -79.3% | 150 | -83.3% | 0.01% | -82.1% |
| Q2 2016 | $82,000 | +26.2% | 900 | 0.0% | 0.03% | +3.7% |
| Q1 2016 | $65,000 | +4.8% | 900 | 0.0% | 0.03% | -53.4% |
| Q4 2015 | $62,000 | – | 900 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |